Phenotype submission - Cognitive impairment
|
|
1
|
108
|
September 18, 2023
|
Phenotype Submission - Rheumatoid Arthritis
|
|
2
|
134
|
September 18, 2023
|
Phenotype Submission - Migraine
|
|
1
|
97
|
September 18, 2023
|
Phenotype submission - Surgical wound infection
|
|
1
|
118
|
September 18, 2023
|
Phenotype submission - Intraabdominal abscess
|
|
1
|
104
|
September 18, 2023
|
Phenotype submission - Intestinal obstruction
|
|
1
|
98
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum, no surgery or oncological treatment
|
|
1
|
98
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum surgical treatment
|
|
1
|
93
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum oncological treatment, no surgery
|
|
1
|
108
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, treated with potentially curative surgery
|
|
1
|
110
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, no surgery and no oncological treatment
|
|
1
|
93
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
91
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
91
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, surgical treatment
|
|
1
|
90
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
92
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum, MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
80
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum MSI-H or dMMR
|
|
1
|
74
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of rectum
|
|
1
|
73
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, no surgery or oncological treatment
|
|
1
|
80
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, oncological treatment, no surgery
|
|
1
|
70
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR, surgically treatment
|
|
1
|
71
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-H or dMMR
|
|
1
|
71
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, no surgery or oncological treatment
|
|
1
|
64
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon MSI-L, MSI-indeterminate, MSS or pMMR, oncological treatment, no surgery
|
|
1
|
67
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR, surgically treated
|
|
1
|
62
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon, MSI-L, MSI-indeterminate, MSS or pMMR
|
|
1
|
76
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon oncological treatment, no surgery
|
|
1
|
75
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon surgical treatment
|
|
1
|
76
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon, no surgery or oncological treatment
|
|
1
|
68
|
September 18, 2023
|
Phenotype submission - Primary adenocarcinoma of colon
|
|
1
|
72
|
September 18, 2023
|